메뉴 건너뛰기




Volumn 121, Issue 3, 2009, Pages 52-60

Management of diabetes in patients with chronic kidney disease

Author keywords

Antidiabetic medications; Chronic kidney disease; Diabetes; Diabetic kidney disease; Dialysis; Renal disease

Indexed keywords

ACARBOSE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; CARVEDILOL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EXENDIN 4; GLICLAZIDE; GLIPIZIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; MIGLITOL; MINOXIDIL; NATEGLINIDE; PIOGLITAZONE; PRAMLINTIDE; PREDNISONE; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; TACROLIMUS; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT;

EID: 67549086581     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.05.2002     Document Type: Review
Times cited : (8)

References (77)
  • 1
    • 0025167093 scopus 로고
    • Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II
    • Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39(9):1116-1124.
    • (1990) Diabetes , vol.39 , Issue.9 , pp. 1116-1124
    • Orchard, T.J.1    Dorman, J.S.2    Maser, R.E.3
  • 3
    • 14044256959 scopus 로고    scopus 로고
    • US Renal Data System. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
    • US Renal Data System. USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
    • (2004) USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States
  • 4
    • 0035856920 scopus 로고    scopus 로고
    • Global and societal implications of the diabetes epidemic
    • DOI 10.1038/414782a
    • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787. (Pubitemid 34000780)
    • (2001) Nature , vol.414 , Issue.6865 , pp. 782-787
    • Zimmet, P.1    Alberti, K.G.M.M.2    Shaw, J.3
  • 5
    • 0025950787 scopus 로고
    • Mechanisms of diabetic hyperfiltration
    • Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int. 1991;40(4):792-807.
    • (1991) Kidney Int , vol.40 , Issue.4 , pp. 792-807
    • Bank, N.1
  • 6
    • 0026551330 scopus 로고
    • Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus
    • Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int. 1992;41(4):829-835.
    • (1992) Kidney Int , vol.41 , Issue.4 , pp. 829-835
    • Vora, J.P.1    Dolben, J.2    Dean, J.D.3
  • 8
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am Kidney Dis. 2002;39(suppl 1):S1-S266.
    • (2002) Am Kidney Dis , vol.39 , Issue.SUPPL. 1
  • 9
    • 0030377443 scopus 로고    scopus 로고
    • Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio
    • Warram JH, Gearing G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7(6):930-937. (Pubitemid 27465988)
    • (1996) Journal of the American Society of Nephrology , vol.7 , Issue.6 , pp. 930-937
    • Warram, J.H.1    Gearin, G.2    Laffel, L.3    Krolewski, A.S.4
  • 10
    • 33845760213 scopus 로고    scopus 로고
    • KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
    • DOI 10.1053/j.ajkd.2006.12.005, PII S0272638606018439
    • KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154. (Pubitemid 46185743)
    • (2007) American Journal of Kidney Diseases , vol.49 , Issue.2 SUPPL. 2
  • 13
    • 0026734156 scopus 로고
    • Renal injury from angiotensin II-mediated hypertension
    • Johnson RJ, Alpers CE, Yoshimura A, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19(5):464-474.
    • (1992) Hypertension , vol.19 , Issue.5 , pp. 464-474
    • Johnson, R.J.1    Alpers, C.E.2    Yoshimura, A.3
  • 14
    • 35348917135 scopus 로고    scopus 로고
    • Management of Glycemia in Patients with Diabetes Mellitus and CKD
    • DOI 10.1053/j.ajkd.2007.08.012, PII S0272638607011493
    • Lubowsky ND, Siegel R, Pittas AG. Management of glycemia in patients with diabetes mellitus and CKD. Am J Kidney Dis. 2007;50(5):865-879. (Pubitemid 47588565)
    • (2007) American Journal of Kidney Diseases , vol.50 , Issue.5 , pp. 865-879
    • Lubowsky, N.D.1    Siegel, R.2    Pittas, A.G.3
  • 16
    • 20544476937 scopus 로고    scopus 로고
    • Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease
    • DOI 10.1681/ASN.2004060447
    • Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16(2):459-466. (Pubitemid 41725142)
    • (2005) Journal of the American Society of Nephrology , vol.16 , Issue.2 , pp. 459-466
    • Poggio, E.D.1    Wang, X.2    Greene, T.3    Van Lente, F.4    Hall, P.M.5
  • 17
    • 24344499832 scopus 로고    scopus 로고
    • An alternative formula to the cockcroft-gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes
    • DOI 10.1681/ASN.2004080692
    • Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol. 2005;16(4):1051-1060. (Pubitemid 41710315)
    • (2005) Journal of the American Society of Nephrology , vol.16 , Issue.4 , pp. 1051-1060
    • Ibrahim, H.1    Mondress, M.2    Tello, A.3    Fan, Y.4    Koopmeiners, J.5    Thomas, W.6
  • 18
    • 0345505677 scopus 로고    scopus 로고
    • Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions
    • DOI 10.2337/diabetes.52.4.1036
    • Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52(4):1036-1040. (Pubitemid 36384275)
    • (2003) Diabetes , vol.52 , Issue.4 , pp. 1036-1040
    • Caramori, M.L.1    Fioretto, P.2    Mauer, M.3
  • 19
    • 0026683655 scopus 로고
    • Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion
    • Lane PH, Steffes MW, Mauer SM. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes. 1992;41(5):581-586.
    • (1992) Diabetes , vol.41 , Issue.5 , pp. 581-586
    • Lane, P.H.1    Steffes, M.W.2    Mauer, S.M.3
  • 20
    • 38349019064 scopus 로고    scopus 로고
    • Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits
    • Jacob J, Tsao PS. Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits. Am J Nephrol. 2007;28(2):224-237.
    • (2007) Am J Nephrol , vol.28 , Issue.2 , pp. 224-237
    • Jacob, J.1    Tsao, P.S.2
  • 21
    • 33947266626 scopus 로고    scopus 로고
    • Relationship between arterial hypertension and renal damage in chronic kidney disease: Insights from ABPM
    • Paoletti E, Bellino D, Amidone M, Rolla D, Cannella G. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM. J Nephrol. 2006;19(6):778-782. (Pubitemid 46415984)
    • (2006) Journal of Nephrology , vol.19 , Issue.6 , pp. 778-782
    • Paoletti, E.1    Bellino, D.2    Amidone, M.3    Rolla, D.4    Cannella, G.5
  • 22
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • DOI 10.1016/S0140-6736(98)07019-6
    • UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853. (Pubitemid 28416718)
    • (1998) Lancet , vol.352 , Issue.9131 , pp. 837-853
    • Turner, R.1
  • 23
    • 7744237066 scopus 로고    scopus 로고
    • Metabolic effects of carvedilol vs metoprotol in patients with type 2 diabetes mellinis and hypertension
    • Bakris GL, Fonesca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprotol in patients with type 2 diabetes mellinis and hypertension. JAMA. 2004;292(18):2227-2236.
    • (2004) JAMA , vol.292 , Issue.18 , pp. 2227-2236
    • Bakris, G.L.1    Fonesca, V.2    Katholi, R.E.3
  • 24
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • Fellström BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360(14):1395-1407.
    • (2009) N Engl J Med , vol.360 , Issue.14 , pp. 1395-1407
    • Fellström, B.C.1    Jardine, A.G.2    Schmieder, R.E.3
  • 28
    • 0025910414 scopus 로고
    • Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement insulin-dependent diabetes mellitus
    • Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement insulin-dependent diabetes mellitus. N Engl J Med. 1991;324(23):1626-1632.
    • (1991) N Engl J Med , vol.324 , Issue.23 , pp. 1626-1632
    • Tuttle, K.R.1    Bruton, J.L.2    Perusek, M.C.3    Lancaster, J.L.4    Kopp, D.T.5    Defronzo, R.A.6
  • 29
    • 0027319737 scopus 로고
    • Effects of insulin-like growth factor I on renal function in normal men
    • Hirschberg R, Brunori G, Kopple JD, Guler HP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 1993;43(2):387-397. (Pubitemid 23162832)
    • (1993) Kidney International , vol.43 , Issue.2 , pp. 387-397
    • Hirschberg, R.1    Brunori, G.2    Kopple, J.D.3    Guler, H.-P.4
  • 30
    • 0026827633 scopus 로고
    • The growth hormone-insulin-like growth factor I axis and renal glomerular filtration
    • Hirschberg R, Kopple JD. The growth hormone-insulin-like growth factor I axis and renal glomerular filtration. J Am Soc Nephrol. 1992;2(9):1417-1422.
    • (1992) J Am Soc Nephrol , vol.2 , Issue.9 , pp. 1417-1422
    • Hirschberg, R.1    Kopple, J.D.2
  • 31
    • 0030005523 scopus 로고    scopus 로고
    • Protein glycation in the kidney: Role in diabetes and aging
    • Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Int. 1996;49(6):1795-1804. (Pubitemid 26188071)
    • (1996) Kidney International , vol.49 , Issue.6 , pp. 1795-1804
    • Vlassara, H.1
  • 33
    • 0034118392 scopus 로고    scopus 로고
    • Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
    • DOI 10.1046/j.1523-1755.2000.00031.x
    • Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 2000;57(5):1803-1817. (Pubitemid 30252273)
    • (2000) Kidney International , vol.57 , Issue.5 , pp. 1803-1817
    • Taal, M.W.1    Brenner, B.M.2
  • 34
    • 0347133334 scopus 로고    scopus 로고
    • Poor Control of Risk Factors for Vascular Disease among Adults with Previously Diagnosed Diabetes
    • DOI 10.1001/jama.291.3.335
    • Saydah SB, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335-342. (Pubitemid 38101606)
    • (2004) Journal of the American Medical Association , vol.291 , Issue.3 , pp. 335-342
    • Saydah, S.H.1    Fradkin, J.2    Cowie, C.C.3
  • 35
    • 0034627208 scopus 로고    scopus 로고
    • Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
    • Mogensen CE, Neldam S, Tikkanen I, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321(7274):1440-1444.
    • (2000) BMJ , vol.321 , Issue.7274 , pp. 1440-1444
    • Mogensen, C.E.1    Neldam, S.2    Tikkanen, I.3
  • 36
    • 20444494954 scopus 로고    scopus 로고
    • Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: The role of aldosterone
    • DOI 10.1055/s-2005-861359
    • Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nepbropathy: the role of aldosterone. Horm Metab Res. 2005;37(suppl 1):4-8. (Pubitemid 40813887)
    • (2005) Hormone and Metabolic Research , vol.37 , Issue.SUPPL. 1
    • Schjoedt, K.J.1    Jacobsen, P.2    Rossing, K.3    Boomsma, F.4    Parving, H.H.5
  • 39
    • 42049107348 scopus 로고    scopus 로고
    • Telmisartan, ramipril, or both in patients at high risk for vascular events
    • Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559.
    • (2008) N Engl J Med , vol.358 , Issue.15 , pp. 1547-1559
    • Yusuf, S.1    Teo, K.K.2    Pogue, J.3
  • 40
    • 33845367689 scopus 로고    scopus 로고
    • Drug interactions of medications commonly used in diabetes
    • DOI 10.2337/diaspect.19.4.202
    • Triplitt C. Drug interactions of medications commonly used in diabetes. Diabetes Spectrum. 2006;19:202-211. (Pubitemid 44885518)
    • (2006) Diabetes Spectrum , vol.19 , Issue.4 , pp. 202-211
    • Triplitt, C.1
  • 41
    • 0027286787 scopus 로고
    • Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes
    • DOI 10.1016/0140-6736(93)90816-Y
    • Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet. 1993;341(8856)1:1306-1309. (Pubitemid 23148093)
    • (1993) Lancet , vol.341 , Issue.8856 , pp. 1306-1309
    • Wang, P.H.1    Lau, J.2    Chalmers, T.C.3
  • 42
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellilus
    • The Diabetes Control and Complications Trial Rcscarch Group
    • The Diabetes Control and Complications Trial Rcscarch Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellilus. N Engl J Med. 1993;329(14):977-986.
    • (1993) N Engl J Med , vol.329 , Issue.14 , pp. 977-986
  • 43
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-117.
    • (1995) Diabetes Res Clin Pract , vol.28 , Issue.2 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 46
    • 0034071036 scopus 로고    scopus 로고
    • Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients
    • Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(suppl 2):B21-B29. (Pubitemid 30185774)
    • (2000) Diabetes Care , vol.23 , Issue.SUPPL. 2
    • Shichiri, M.1    Kishikawa, H.2    Ohkubo, Y.3    Wake, N.4
  • 47
    • 0027275397 scopus 로고
    • The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
    • DOI 10.1056/NEJM199307293290502
    • Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993;329(5):304-309. (Pubitemid 23210681)
    • (1993) New England Journal of Medicine , vol.329 , Issue.5 , pp. 304-309
    • Reichard, P.1    Nilsson, B.-Y.2    Rosenqvist, U.3
  • 48
    • 33746588255 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. a consensus statement from the American diabetes association and the European association for the study of diabetes
    • DOI 10.2337/dc06-9912
    • Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29(8):1963-1972. (Pubitemid 44156663)
    • (2006) Diabetes Care , vol.29 , Issue.8 , pp. 1963-1972
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Heine, R.J.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 49
    • 0031053808 scopus 로고    scopus 로고
    • An overview of metformin in the treatment of type 2 diabetes mellitus
    • DOI 10.1016/S0002-9343(96)00353-1, PII S0002934396003531
    • Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997;102(1):99-110. (Pubitemid 27089992)
    • (1997) American Journal of Medicine , vol.102 , Issue.1 , pp. 99-110
    • Davidson, M.B.1    Peters, A.L.2
  • 50
    • 20844435106 scopus 로고    scopus 로고
    • Oral antihyperglycemic agents and renal disease: New agents, new concepts
    • DOI 10.1681/ASN.2004110974
    • Yale JF. Oral antihyperglycemic agents and renal disease: new agents, new concepts. J Am Soc Nephrol. 2005;16(suppl 1):S7-S10. (Pubitemid 41725074)
    • (2005) Journal of the American Society of Nephrology , vol.16 , Issue.3 SUPPL. 1
    • Yale, J.-F.1
  • 52
    • 0037365688 scopus 로고    scopus 로고
    • Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure
    • DOI 10.1016/S0168-8227(02)00242-5, PII S0168822702002425
    • Nagai T, Imamura M, Iizuka K, Mori M. Hypoglycemia due to nateglinide administration in diabetic patient with chronic renal failure. Diabetes Res Clin Pract. 2003;59(3):19l-194. (Pubitemid 36183302)
    • (2003) Diabetes Research and Clinical Practice , vol.59 , Issue.3 , pp. 191-194
    • Nagai, T.1    Imamura, M.2    Iizuka, K.3    Mori, M.4
  • 54
    • 7044271016 scopus 로고    scopus 로고
    • Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease
    • DOI 10.1111/j.0894-0959.2004.17346.x
    • Snyder RW, Berns JS. Use of insulin and oral hypoglcemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004;17(5):365-370. (Pubitemid 39422090)
    • (2004) Seminars in Dialysis , vol.17 , Issue.5 , pp. 365-370
    • Snyder, R.W.1    Berns, J.S.2
  • 56
    • 0034758754 scopus 로고    scopus 로고
    • Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria
    • DOI 10.1053/meta.2001.26703
    • Nakamura T, Ushiyama C, Osada S, Hara M, Shimada N, Koide H. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism. 2001;50(10):1193-1196. (Pubitemid 33034703)
    • (2001) Metabolism: Clinical and Experimental , vol.50 , Issue.10 , pp. 1193-1196
    • Nakamura, T.1    Ushiyama, C.2    Osada, S.3    Hara, M.4    Shimada, N.5    Koide, H.6
  • 59
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457-2471. (Pubitemid 46919772)
    • (2007) New England Journal of Medicine , vol.356 , Issue.24 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2
  • 60
    • 67649177574 scopus 로고    scopus 로고
    • US Food and Drug Administration Accessed April 30, 2009
    • US Food and Drug Administration. http://www.accessdata.fda.gov/scripts/ cder/drugsatfda/index.cfm?fuseaction=Search.Label-ApprovalHistory. Accessed April 30, 2009.
  • 61
    • 34548590934 scopus 로고    scopus 로고
    • Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus
    • Lincoff MA, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus. JAMA. 2007;298(10):1180-1188.
    • (2007) JAMA , vol.298 , Issue.10 , pp. 1180-1188
    • Lincoff, M.A.1    Wolski, K.2    Nicholls, S.J.3    Nissen, S.E.4
  • 62
    • 11844250564 scopus 로고    scopus 로고
    • Insulin analogues
    • DOI 10.1056/NEJMra040832
    • Hirsch IB. Insulin analogues. N Engl J Med. 2005;352(2):174-183. (Pubitemid 40096614)
    • (2005) New England Journal of Medicine , vol.352 , Issue.2 , pp. 174-183
    • Hirsch, I.B.1
  • 63
    • 31544464630 scopus 로고    scopus 로고
    • Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus [8]
    • DOI 10.1093/ndt/gfi205
    • Ersoy A, Ersoy C, Altinay T. Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus. Nephrol Dial Transplant. 2006;21(2):553-554. (Pubitemid 43160027)
    • (2006) Nephrology Dialysis Transplantation , vol.21 , Issue.2 , pp. 553-554
    • Ersoy, A.1    Ersoy, C.2    Altinay, T.3
  • 64
    • 0033661254 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of subcutaneous injection of long acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
    • Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000:49(12);2l42-2148.
    • (2000) Diabetes , vol.49 , Issue.12
    • Lepore, M.1    Pampanelli, S.2    Fanelli, C.3
  • 65
    • 33645967817 scopus 로고    scopus 로고
    • Insulin detemir under steady state conditions: No accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes
    • Butt S, Tusek C, Jacobsen LV, et al. Insulin detemir under steady state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes. Diabetic Medicine. 2006;23:522-528.
    • (2006) Diabetic Medicine , vol.23 , pp. 522-528
    • Butt, S.1    Tusek, C.2    Jacobsen, L.V.3
  • 66
    • 0035656524 scopus 로고    scopus 로고
    • Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration
    • Quellhorst E. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol. 2002;13(suppl 1):S92-96.
    • (2002) J Am Soc Nephrol , vol.13 , Issue.SUPPL. 1
    • Quellhorst, E.1
  • 68
    • 33645231696 scopus 로고    scopus 로고
    • The effect of glucose added to the dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients: A placebo-controlled crossover study
    • Sangill M, Pedersen EB. The effect of glucose added to the dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients: a placebo-controlled crossover study. Am J Kidney Dis. 2006,47(4):636-643.
    • (2006) Am J Kidney Dis , vol.47 , Issue.4 , pp. 636-643
    • Sangill, M.1    Pedersen, E.B.2
  • 69
    • 0037373850 scopus 로고    scopus 로고
    • Assessing glycemic control in patients with diabetes and end-stage renal failure
    • DOI 10.1053/ajkd.2003.50114
    • Ansari A, Thomas S, Goldsmith D. Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis. 2003;41(3):523-531. (Pubitemid 36278368)
    • (2003) American Journal of Kidney Diseases , vol.41 , Issue.3 , pp. 523-531
    • Ansari, A.1    Thomas, S.2    Goldsmith, D.3
  • 71
    • 0033031089 scopus 로고    scopus 로고
    • Risk for posttransplant diabetes mellitus with current immunosuppressive medications
    • Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1-13. (Pubitemid 29318789)
    • (1999) American Journal of Kidney Diseases , vol.34 , Issue.1 , pp. 1-13
    • Weir, M.R.1    Fink, J.C.2
  • 72
    • 33846680173 scopus 로고    scopus 로고
    • Early steroid withdrawal therapy in renal transplant recipients: A steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol
    • DOI 10.1111/j.1399-0012.2006.00613.x
    • Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Early steroid withdrawal therapy in renal transplantation recipients: a steroid free sirolimus and CellCept based calcineurin inhibitor-minimization protocol. Clin Transplant. 2007;21(1):101-109. (Pubitemid 46189594)
    • (2007) Clinical Transplantation , vol.21 , Issue.1 , pp. 101-109
    • Jaber, J.J.1    Feustel, P.J.2    Elbahloul, O.3    Conti, A.D.4    Gallichio, M.H.5    Conti, D.J.6
  • 73
    • 0030951564 scopus 로고    scopus 로고
    • Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: A prospective trial in renal transplants
    • DOI 10.1007/s001470050041
    • Kim YS, Kim MS, Kim SI, Lim SK, Lee HY, Han DS, Park K. Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants. Transpl Int. 1997;10(3):197-201. (Pubitemid 27174073)
    • (1997) Transplant International , vol.10 , Issue.3 , pp. 197-201
    • Kim, Y.S.1    Kim, M.S.2    Kim, S.I.3    Lim, S.K.4    Lee, H.Y.5    Han, D.S.6    Park, K.7
  • 75
    • 0020526172 scopus 로고
    • Reversible diminished insulin requirement during acute renal failure
    • Naschitz JE, Barak C, Yeshurun D. Reversible diminished insulin requirement during acute renal failure. Postgrad Med J. 1983;59(690):269-27l.
    • (1983) Postgrad Med J , vol.59 , Issue.690
    • Naschitz, J.E.1    Barak, C.2    Yeshurun, D.3
  • 76
    • 0035199665 scopus 로고    scopus 로고
    • Lower-extremity peripheral arterial disease among patients with end-stage renal disease
    • O'Hare A, Johansen K. Lower extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol. 2001;12(12):2838-2847. (Pubitemid 33115433)
    • (2001) Journal of the American Society of Nephrology , vol.12 , Issue.12 , pp. 2838-2847
    • O'Hare, A.1    Johansen, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.